@article{24877,
  keywords = {Animals, Anti-Bacterial Agents, Antimalarials, Antiviral Agents, Humans, leprosy, Malaria, Malaria, Cerebral, Nervous System Diseases, Rabies, Tetanus},
  author = {Murthy J M K and Dastur F and Khadilkar S and Kochar D},
  title = {Rabies, tetanus, leprosy, and malaria.},
  abstract = {The developing world is still endemic to rabies, tetanus, leprosy, and malaria. Globally more than 55000 people die of rabies each year, about 95% in Asia and Africa. Annually, more than 10 million people, mostly in Asia, receive postexposure vaccination against the disease. World Health Organization estimated tetanus-related deaths at 163000 in 2004 worldwide. Globally, the annual detection of new cases of leprosy continues to decline and the global case detection declined by 3.54% during 2008 compared to 2007. Malaria is endemic in most countries, except the US, Canada, Europe, and Russia. Malaria accounts for 1.5-2.7 million deaths annually. Much of the disease burden related to these four infections is preventable.},
  year = {2014},
  journal = {Handbook of clinical neurology},
  volume = {121},
  pages = {1501-20},
  month = {2014},
  issn = {0072-9752},
  doi = {10.1371/journal.pntd.0002845},
  language = {eng},
}